Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $145.5650 (1.5%) ($142.3200 - $145.5650) on Fri. Jul. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.98% (three month average) | RSI | 25 | Latest Price | $145.5650(1.5%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(49%) XBI(42%) ARKG(35%) IWO(34%) IVW(31%) | Factors Impacting SGEN price | SGEN will decline at least -0.99% in a week (0% probabilities). VIXM(-24%) VXX(-10%) UUP(-7%) TBT(-3%) USO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.99% (StdDev 1.98%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $149.41 | 5 Day Moving Average | $144.47(0.76%) | 10 Day Moving Average | $144.42(0.79%) | 20 Day Moving Average | $149.41(-2.57%) | To recent high | -10.1% | To recent low | 7.7% | Market Cap | $25.309b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |